Skip to content

Clinical trials

Terminated Phase 2 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Status: Terminated Clear all

419 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20025
200314
200420
200516
200619
200735
200834
200928
201021
201122
201218
201326
201416
201523
201614
201719
201814
201919
202014
202110
20228
20237
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated419

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center15
Hoffmann-La Roche11
National Cancer Institute (NCI)11
Washington University School of Medicine11
Dana-Farber Cancer Institute9
Pfizer8
Emory University7
Hellenic Oncology Research Group6
Masonic Cancer Center, University of Minnesota6
Baylor Breast Care Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms419
Neoplasm Metastasis33
Triple Negative Breast Neoplasms28
Breast Neoplasms, Male17
Neoplasms14
Lung Neoplasms12
Ovarian Neoplasms11
Breast Carcinoma In Situ10
Brain Neoplasms9
Colorectal Neoplasms8

Trials

Showing 1 to 25 of 419. Each trial links to its page on Pharma Observatory.

319 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.